Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  ICON Public Limited Company    ICLR   IE0005711209

ICON PUBLIC LIMITED COMPANY

(ICLR)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Summary
  • The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
  • In a short-term perspective, the company has interesting fundamentals.
Strengths
  • The company is in a robust financial situation considering its net cash and margin position.
  • There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
  • The stock is in a well-established, long-term rising trend above the technical support level at 159.73 USD
Weaknesses
  • Stock prices approach a strong long-term resistance in weekly data at USD 216.24.
  • Technically, the stock approaches a strong medium-term resistance at USD 220.96.
  • The company benefits from high valuations in earnings multiples.
Ratings chart
Sector Biotechnology & Medical Research - Other
1st jan.Capitalisation (M$)Investor Rating
ICON PUBLIC LIMITED COMPANY9.29%11 326
MODERNA, INC.45.35%58 169
LONZA GROUP AG6.79%50 766
CELLTRION, INC.-10.58%39 697
IQVIA HOLDINGS INC.0.65%35 090
SEAGEN INC.-1.43%32 583
HANGZHOU TIGERMED CONSULTIN..18.50%25 245
INCYTE CORPORATION15.54%22 009
ALNYLAM PHARMACEUTICALS, IN..30.81%20 412
PHARMARON BEIJING CO., LTD.40.91%20 367
BIO-TECHNE CORPORATION7.18%13 607
CHARLES RIVER LABORATORIES ..9.48%13 607
CRISPR THERAPEUTICS AG18.37%13 396
QIAGEN N.V.-0.89%12 246
PPD, INC.1.99%12 203
IONIS PHARMACEUTICALS, INC.10.58%8 918
More Results
Financials (USD)
Sales 2020 2 788 M - -
Net income 2020 330 M - -
Net cash 2020 309 M - -
P/E ratio 2020 34,5x
Yield 2020 -
Capitalization 11 246 M 11 246 M -
EV / Sales 2020 3,92x
EV / Sales 2021 3,40x
Nbr of Employees 15 250
Free-Float 98,5%
Upcoming event on ICON PUBLIC LIMITED COMPANY
Notations Surperformance©
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield -
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes